​

Praxis Precision Medicines (PRAX) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChartTranscripts

PRAX Stock Forecast

Praxis Precision Medicines (PRAX) stock forecast, based on 16 Wall Street analysts, predicts a 12-month average price target of $578.86, with a high of $1,201.00 and a low of $162.00. This represents a 77.95% increase from the last price of $325.30.

- $300 $600 $900 $1 $1 High: $1201 Avg: $578.86 Low: $162 Last Closed Price: $325.3

PRAX Stock Rating

Praxis Precision Medicines stock's rating consensus is Buy, based on 16 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 12 Buy (75.00%), 3 Hold (18.75%), 1 Sell (6.25%), and 0 Strong Sell (0.00%).

Buy
Total 16 0 1 3 12 Strong Sell Sell Hold Buy Strong Buy

PRAX Price Target Upside V Benchmarks

TypeNameUpside
StockPraxis Precision Medicines77.95%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts21447
Avg Price Target$511.00$587.86$497.66
Last Closing Price$325.30$325.30$325.30
Upside/Downside57.09%80.71%52.98%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 2631311-18
Jun, 2621311-17
May, 2621311-17
Apr, 2621211-16
Mar, 2621311-17
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 13, 2026Goldman Sachs$447.00$324.9937.54%37.41%
Jun 29, 2026Ami FadiaNeedham$575.00$329.5274.50%76.76%
Jun 17, 2026Leonid TimashevRBC Capital$449.00$270.0166.29%38.03%
Jun 02, 2026Truist Financial$616.00$306.06101.27%89.36%
Jun 02, 2026Wedbush$162.00$335.16-51.66%-50.20%
Jun 02, 2026Jay OlsonOppenheimer$650.00$335.1693.94%99.82%
Jun 02, 2026Robert W. Baird$400.00$335.1619.35%22.96%
Jun 02, 2026H.C. Wainwright$1.20K$335.16258.34%269.20%
Jun 02, 2026Kambiz YazdiBTIG$810.00$335.16141.68%149.00%
Jun 02, 2026David HoangDeutsche Bank$374.00$335.1611.59%14.97%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 13, 2026Piper SandlerOverweightOverweighthold
Jul 13, 2026Goldman SachsBuyinitialise
Jun 29, 2026NeedhamBuyBuyhold
Jun 17, 2026RBC CapitalOutperforminitialise
Jun 02, 2026Cowen & Co.BuyBuyhold
Jun 02, 2026OppenheimerOutperformOutperformhold
Jun 02, 2026BTIGBuyBuyhold
Jun 02, 2026Deutsche BankBuyBuyhold
May 26, 2026H.C. WainwrightBuyBuyhold
May 08, 2026WedbushUnderperformUnderperformhold

Financial Forecast

EPS Forecast

$-25 $-20 $-15 $-10 $-5 $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-18.69$-10.21$-13.48---
Avg Forecast$-20.43$-10.20$-11.47$-11.46$-9.52$-2.37
High Forecast$-14.03$-10.07$-8.88$-6.61$-3.02$-1.09
Low Forecast$-24.96$-10.32$-13.94$-19.33$-17.04$-3.75
Surprise %-8.52%0.10%17.52%---

Revenue Forecast

$0 $90M $180M $270M $360M $450M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.45M$8.55M----
Avg Forecast$1.90M$1.47M$967.30K$31.98M$101.46M$308.29M
High Forecast$2.14M$1.83M$1.40M$46.35M$147.04M$446.80M
Low Forecast$1.82M$1.09M$565.43K$18.70M$59.31M$180.21M
Surprise %28.79%483.42%----

Net Income Forecast

$-350M $-280M $-210M $-140M $-70M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-123.28M$-182.82M$-303.27M---
Avg Forecast$-123.28M$-67.22M$-75.24M$-85.53M$-66.14M$-15.63M
High Forecast$-92.52M$-66.40M$-58.53M$-43.59M$-19.92M$-7.19M
Low Forecast$-164.62M$-68.04M$-91.95M$-127.47M$-112.35M$-24.76M
Surprise %-171.96%303.07%---

PRAX Forecast FAQ

Is Praxis Precision Medicines stock a buy?

Praxis Precision Medicines stock has a consensus rating of Buy, based on 16 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 12 Buy, 3 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Praxis Precision Medicines is a favorable investment for most analysts.

What is Praxis Precision Medicines's price target?

Praxis Precision Medicines's price target, set by 16 Wall Street analysts, averages $578.86 over the next 12 months. The price target range spans from $162 at the low end to $1.2K at the high end, suggesting a potential 77.95% change from the previous closing price of $325.3.

How does Praxis Precision Medicines stock forecast compare to its benchmarks?

Praxis Precision Medicines's stock forecast shows a 77.95% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Praxis Precision Medicines over the past three months?

  • July 2026: 16.67% Strong Buy, 72.22% Buy, 5.56% Hold, 5.56% Sell, 0% Strong Sell.
  • June 2026: 11.76% Strong Buy, 76.47% Buy, 5.88% Hold, 5.88% Sell, 0% Strong Sell.
  • May 2026: 11.76% Strong Buy, 76.47% Buy, 5.88% Hold, 5.88% Sell, 0% Strong Sell.

What is Praxis Precision Medicines’s EPS forecast?

Praxis Precision Medicines's average annual EPS forecast for its fiscal year ending in December 2026 is $-11.46, marking a -14.99% decrease from the reported $-13.48 in 2025. Estimates for the following years are $-9.52 in 2027, and $-2.37 in 2028.

What is Praxis Precision Medicines’s revenue forecast?

Praxis Precision Medicines's average annual revenue forecast for its fiscal year ending in December 2026 is $31.98M, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $101.46M, and $308.29M for 2028.

What is Praxis Precision Medicines’s net income forecast?

Praxis Precision Medicines's net income forecast for the fiscal year ending in December 2026 stands at $-85.528M, representing a -71.80% decrease from the reported $-303M in 2025. Projections indicate $-66.138M in 2027, and $-15.629M in 2028.